Multi-Infarct Dementia Market: By Causes (Anemia, Brain Tumor, Chronic Infection, Depression, Thyroid Disease, Othes), By Pharmacological Treatment (Cheis, Donepezil, Galantamine, Rivastigmine, Others) & By Region - Forecast(2018 - 2023)

Report Code : HCR 0295 Format Type: PDF+ Excel Database

Multi-infarct dementia (MID) is one of the common causes of memory loss among elderly people as a result of reduced blood flow to parts of the brain. The primary reason for multi-infarct dementia is a series of minor strokes resulting in disruption of blood flow leading towards the brain. Globally, Development of efficient and advance technology, Rise in the demand for noval diagnostic Product. Rising demand for point of care devices segment and Growing demand for Multi-Infarct Dementias demand in end-use industries are the prime growth drivers of global Near Infrared Imaging market. In addition, increase in adoption of Multi-Infarct Dementia for newer applications, will create new opportunities for global Near multi infarct dementia market. However, higher cost of the research and development, lack of awareness and Sustainability in market are the key restraints for global Near Infrared Imaging market.

This report identifies the global Multi-Infarct Dementia market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global Multi-Infarct Dementia market.
 
Multi-Infarct Dementia Market

Geographically North America dominated global Multi-Infarct Dementia market, and Europe is projected to have fastest growth, while it is the most common type of dementia in Asia and other parts of the world. For instance, it accounts for more than 50% of dementia cases in Japan. The prevalence of multi-infarct dementia (MID) is expected to rise drastically in the near future given the exponential rise in geriatric population of the world. Therefore, the global multi-infarct dementia (MID) market is expected to grow rapidly in the developed nations such as the U.S., Canada, Germany, France, and Japan where there is enormous rise in the elderly people.

This report segments global Multi-Infarct Dementia market on the basis of product type, application, end-user, and regional market as follows:
  • Multi-Infarct Dementia Market, By Causes (Anemia, Brain Tumor, Chronic Infection, Depression, Thyroid Disease, Vitamin Deficiency, Drug Intoxication and Others
  • Multi-Infarct Dementia Market, By Pharmacological Treatment (Cheis, Donepezil, Galantamine, Rivastigmine, Memantine, Nimodipine,Hydergine, CDP-Choline) and Others
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Multi-Infarct Dementia market. Some of the major companies’ profiles in detail are as follows:
  • Accelerys Inc.
  • Affymetrix
  • Agilent technologies
  • Celera Corporation
  • DNAnexus

PLEASE SELECT LICENCE

Request Sample Data